Skip to content

Lung Nodule Imaging Biobank for Radiomics and AI Research

Lung Nodule Imaging Biobank for Radiomics and AI Research

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04270799
Acronym
LIBRA
Enrollment
1000
Registered
2020-02-17
Start date
2020-06-01
Completion date
2021-08-31
Last updated
2021-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Cancer, Lung Neoplasms, Pulmonary Nodule, Multiple, Pulmonary Nodule, Solitary

Keywords

Incidental lung nodules, Radiomics, Artificial Intelligence, Machine Learning

Brief summary

This study will collect retrospective CT scan images and clinical data from participants with incidental lung nodules seen in hospitals across London. The investigators will research whether machine learning can be used to predict which participants will develop lung cancer, to improve early diagnosis.

Interventions

DIAGNOSTIC_TESTMachine Learning Classification

Patient's scans will be used as input into in-house software to extract multiple radiomics features. These features will be used to develop a risk-signature which can predict malignancy risk. Patient scans will also be used as input into deep learning/convolutional neural network models to perform automated imaging classification.

Sponsors

RM Partners West London Cancer Alliance
CollaboratorUNKNOWN
Royal Brompton & Harefield NHS Foundation Trust
CollaboratorOTHER
University College London Hospitals
CollaboratorOTHER
Imperial College Healthcare NHS Trust
CollaboratorOTHER
Lewisham and Greenwich NHS Trust
CollaboratorOTHER_GOV
King's College Hospital NHS Trust
CollaboratorOTHER
Epsom and St Helier University Hospitals NHS Trust
CollaboratorOTHER
Institute of Cancer Research, United Kingdom
CollaboratorOTHER
Guy's and St Thomas' NHS Foundation Trust
CollaboratorOTHER
UCLH Biomedical Research Centre
CollaboratorUNKNOWN
Royal Marsden NHS Foundation Trust
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age \> 18 * Baseline CT thorax imaging reported as having pulmonary nodule(s) between 5 and 30mm in the last 10 years. * Ground truth known (either scan data showing stability for 2 years (based on diameter) or one year (based on volumetry), complete resolution, or biopsy-proven malignancy. * Slice thickness \< 2.5mm.

Exclusion criteria

* • Absence of at least one technically adequate CT thorax imaging series (defined by visual inspection of presence of imaging data of the thorax in the DICOM record). * Slice thickness \> 2.5mm. * Imaging \> 10 years old. * Ground truth unknown.

Design outcomes

Primary

MeasureTime frameDescription
Development of an imaging biobank1 yearThe primary endpoint will be met if we are able to store baseline CT scans and the minimum clinical data set for 1000 patients.

Secondary

MeasureTime frameDescription
Discovery of a CT-thorax based radiomics profile to predict cancer risk.1 yearWe aim to identify distinct clusters of radiomics variables to generate a radiomics predictive vector (RPV), which can be used to stratify patients according to malignancy risk. This vector will be used in multivariate analysis and compared to existing risk models.

Countries

United Kingdom

Contacts

Primary ContactRichard Lee, MBBS PhD
richard.lee@rmh.nhs.uk020 7352 8171

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026